Beauty Health (SKIN) – Research Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of Beauty Health (NASDAQ: SKIN) recently:

• 11/9/2026 – Beauty Health was given a new $14.00 price target by Raymond James Financial.
• 11/9/2026 – Beauty Health had its “hold” rating reaffirmed by TD Cowen. They now have a $14.00 price target on the stock, up from $0.90.
• 10/30/2026 – Beauty Health is now covered by TD Cowen. They set a “hold” rating on the stock.
• 10/22/2026 – Beauty Health was given a new $11.00 price target by Canaccord Genuity Group. They now have a “hold” rating on the stock.
• 10/21/2026 – Beauty Health had its “sell (e+)” rating reaffirmed by Weiss Ratings.
• 10/19/2026 – Beauty Health had its “hold” rating reaffirmed by Jefferies Financial Group. They now have a $11.00 price target on the stock, up from $0.85.
• 10/15/2026 – Beauty Health was given a new $10.00 price target by Stifel Nicolaus.
• 10/15/2026 – Beauty Health had its “hold” rating reaffirmed by Citigroup.

Beauty Health Stock Performance

SKIN traded down $0.30 on Wednesday, reaching $15.63. The stock had a trading volume of 4,840 shares, compared to its average volume of 63,807. The company has a market cap of $101.78 million, a P/E ratio of -5.71 and a beta of 1.05. The Beauty Health Company has a 12-month low of $9.68 and a 12-month high of $33.00. The company has a current ratio of 2.89, a quick ratio of 1.48 and a debt-to-equity ratio of 4.36. The business’s 50-day moving average price is $12.41 and its two-hundred day moving average price is $16.23.

Beauty Health (NASDAQ:SKIN) last issued its quarterly earnings results on Thursday, November 5th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.33) by $1.19. Beauty Health had a negative return on equity of 32.16% and a negative net margin of 6.34%. The company had revenue of $69.17 million for the quarter, compared to the consensus estimate of $67.97 million. Sell-side analysts forecast that The Beauty Health Company will post -2.62 earnings per share for the current year.

BeautyHealth is a global health and beauty company focused on providing technology, products and services for aesthetic and skincare businesses. Its flagship brand, HydraFacial, offers a non-invasive treatment platform that combines cleansing, exfoliation, extraction and hydration, with treatments delivered through proprietary devices and consumable solutions. The company also provides professional skincare products, treatment systems and related solutions designed for use by physicians, dermatologists, aestheticians and other licensed practitioners.